| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |